I've had no side effects, and I'm monitoring my progress through continued research studies. My doctors tell me I'm "buying ...

Caregivers for people with dementia are more likely to report having at least one modifiable risk factor linked to developing dementia.

Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study ...